No Data
The performance in the first year of the bet was thrilling without danger. "The first stock for allergen detection on the Star" Haobor's pressure is beginning to show.
①In 2024, Haobor "barely" achieved its first year's betting target after deducting specific Business; ②2024 marks the first time in seven years that the company's Net income falls below 40 million yuan, and it is also the lowest since landing on the Star.
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Dismal Stock Performance Reflects Weak Fundamentals
Haoubo: 2024 Annual Report of Jiangsu Haoubo Biomedical Co., Ltd.
Haoubo: Summary of the 2024 Annual Report of Jiangsu Haoubo Biomedical Co., Ltd.
Jiangsu Haoubo Biomedical Co., Ltd. 2024 Annual Report
Summary of the 2024 Annual Report of Jiangsu Haoubo Biomedical Co., Ltd.
HOB Biotech Group Corp.,Ltd (SHSE:688656) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
